You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沛嘉醫療-B(09996.HK):GeminiOne® TEER系統及MonarQTM TTVR系統於2023年美國TCT學術會議亮相
格隆匯 10-27 07:38

格隆匯10月27日丨沛嘉醫療-B(09996.HK)發佈公吿,GeminiOne® TEER系統及MonarQTM TTVR系統於2023年美國TCT學術會議亮相。

Los Robles Regional Medical Center心臟病學項目主任及HCA Healthcare介入心臟病學醫師主任Saibal Kar醫學博士在二尖瓣TEER專場中介紹了GeminiOne® TEER系統及該器械的初期臨牀經驗。GeminiOne®為創新TEER器械,目前正在中國醫學科學院阜外醫院的胡盛壽院士及潘湘斌教授領導下於中國進行註冊臨牀研究。美國的早期可行性研究預期將於2024年開始。

心臟外科醫生、inQB8 Medical Technologies, LLC(“inQB8”)聯合創始人、執行主席兼首席醫療官Arshad Quadri醫學博士在三尖瓣疾病及介入專場中分享了MonarQTM的動物實驗及早期首次人體(“FIM”)臨牀試驗的經驗。MonarQTM為集團與inQB8聯合開發的創新TTVR器械。其FIM臨牀試驗正在進行中,且我們正在規劃美國的早期可行性研究。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account